Headlines

Novartis, Roche near US drug price deal, Bloomberg News reports

Published by Global Banking & Finance Review

Posted on December 17, 2025

1 min read

· Last updated: January 20, 2026

Add as preferred source on Google
Novartis, Roche near US drug price deal, Bloomberg News reports
Global Banking & Finance Awards 2026 — Call for Entries

Dec 17 (Reuters) - The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding AG as soon as Friday, Bloomberg News reported on Wednesday

Novartis and Roche Nearing US Drug Price Agreement

Dec ‌17 (Reuters) - ‍The ‌White House is ⁠set ‌to announce ⁠drug pricing ​deals with pharmaceutical ‌heavyweights ⁠Novartis AG and ​Roche Holding AG as soon ​as ‍Friday, ​Bloomberg News reported on Wednesday citing ⁠people familiar ​with the situation.

(Reporting by ‌Sriparna Roy in Bengaluru)

Key Takeaways

  • White House to announce drug pricing deals.
  • Novartis AG and Roche Holding AG involved.
  • Announcement expected as soon as Friday.
  • Bloomberg News cites familiar sources.
  • Potential impact on pharmaceutical industry.

Frequently Asked Questions

What is drug pricing?
Drug pricing refers to the determination of the price at which pharmaceutical products are sold. It involves various factors including production costs, market demand, and regulatory policies.
What is the role of the White House in drug pricing?
The White House can influence drug pricing through policy decisions, regulations, and negotiations with pharmaceutical companies to ensure affordable access to medications for the public.

Tags

Related Articles

More from Headlines

Explore more articles in the Headlines category